Bill Text: TX SB2212 | 2023-2024 | 88th Legislature | Comm Sub

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Engrossed - Dead) 2023-05-06 - Referred to Public Health [SB2212 Detail]

Download: Texas-2023-SB2212-Comm_Sub.html

---

By: Blanco S.B. No. 2212
(In the Senate - Filed March 9, 2023; March 22, 2023, read
first time and referred to Committee on Health & Human Services;
April 25, 2023, reported adversely, with favorable Committee
Substitute by the following vote: Yeas 6, Nays 0; April 25, 2023,
sent to printer.)
Click here to see the committee vote
COMMITTEE SUBSTITUTE FOR S.B. No. 2212 By: Kolkhorst

A BILL TO BE ENTITLED
AN ACT
relating to the disclosure by a pharmacy to a patient of certain
price information for a drug or biological product.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 562.003, Occupations Code, is amended to
read as follows:
Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A
pharmacy shall disclose the lowest cost cash price at that pharmacy
for the drug or biological product prescribed to the patient.
(b) If the price of a drug or biological product to a patient
is lower than the amount of the patient's copayment under the
patient's prescription drug insurance plan, the pharmacist shall
offer the patient the option of paying for the drug or biological
product at the lower price instead of paying the amount of the
copayment.
SECTION 2. This Act takes effect September 1, 2023.
* * * * *